HHS releases cost savings for 64 prescription drugs
The Centers for Medicare and Medicaid Services announced Friday that 64 Part B drugs will have a reduced price for...
Commure acquires patient navigation platform Memora Health
AI and software company Commure has acquired Memora Health, a digital care navigation platform launched out of the Harvard Innovation...
Healthcare executives take a favorable outlook on 2025
Despite significant headwinds coming to bear over the past several years, healthcare executives are expecting a favorable 2025, according to...
Editor’s Corner—A look back at the top 15 stories of 2024
Medicare Advantage, UnitedHealth Group, physician pay and reimbursement and layoffs were top of mind for Fierce Healthcare readers in 2024....
Medline Industries takes steps toward IPO in 2025
Medical equipment and supply manufacturer Medline Industries confidentially submitted plans for a proposed initial public offering, potentially setting the stage...
Walgreens in talks for sale to PE firm: WSJ
Walgreens is weighing a potential sale to a private equity firm, according to a report in The Wall Street Journal....
Anthem faces backlash from new anesthesia policy, reverses course in all states
A recent decision from Anthem Blue Cross Blue Shield in three states to stop paying for anesthesia care in select...
Bristol Myers Squibb latest drug company to sue HHS over 340B rebate model
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it...
Are there lessons to be learned from primary care stumbles?
Just three years ago, primary care was a hot category with major players making sizeable investments to build out healthcare...
New study finds 137M people are eligible for GLP-1s
Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American...
